Eric M. Dube, Chief Executive Officer at Travere Therapeutics, Inc. (TVTX), sold 8,196 shares at $22.25 ($182K) on 2023-02-01, disclosed to the SEC on 2023-02-02.
Open-market sale of $182k TVTX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TVTX | SELL | 2026-04-15 | $2.6M | — | Filing → |
| TVTX | SELL | 2026-04-02 | $1.9M | — | Filing → |
| TVTX | SELL | 2026-02-24 | $1.8M | — | Filing → |